Skip to Main Content

Paper Details

Association of <i>MTHFR</i> Polymorphisms With Leukoencephalopathy Risk in Patients With Primary CNS Lymphoma Treated With Methotrexate-Based Regimens.
Neurology
0
2023
1298AC, 677CT, HD-MTX, Leukoencephalopathy, MTHFR, MTX, Methotrexate, Methylenetetrahydrofolate, Methylenetetrahydrofolate reductase, PCNSL, Patients, Polymorphisms, Primary CNS Lymphoma, folate, leukoencephalopathy, methotrexate, patients, polymorphisms, primary CNS lymphoma
Author NameAffiliation
Priscilla K BrastianosMassachusetts General Hospital, Harvard Medical School, Ludwig-Maximilians-University Munich German Cancer Consortium (DKTK) (P.K.), University of Tuebingen, Brigham and Woman's Hospital
Tracy T BatchelorMassachusetts General Hospital, Harvard Medical School, Ludwig-Maximilians-University Munich German Cancer Consortium (DKTK) (P.K.), University of Tuebingen, Brigham and Woman's Hospital
Tracy T BatchelorMassachusetts General Hospital, Harvard Medical School, Ludwig-Maximilians-University Munich German Cancer Consortium (DKTK) (P.K.), University of Tuebingen, Brigham and Woman's Hospital
  • 1 - 3

Datasets

Release 1.2